Omega Funds

Omega Funds

Omega Funds

Omega Funds global life sciences-based investment firm specialized in direct secondary transactions.
Follow us
Alexa global traffic share
Latest investments Show all
€34,000,000
Venture capital (Series B)
eTheRNA Immunotherapies
$85,000,000
Venture capital (Series C)
Checkmate Pharmaceuticals
Team Size
1–10
Employees
Geographical Focus
Markets focus
Past year's investments
  • 6 rounds in the past year
  • $316.7M deployed in total
  • $52.8M avg per round
Latest rounds
  • eTheRNA Immunotherapies: Venture capital (Series B) (€34M)
  • Checkmate Pharmaceuticals: Venture capital (Series C) ($85M)
  • FoRx Therapeutics: Seed fund (€10M)